Oorsprong van het eerstegraads netwerk van Bill Begien

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 8
Public Company Pharmaceuticals: Major 3

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Bill Begien via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Freda Lewis-Hall

Chief Tech/Sci/R&D Officer

ENCORE CAPITAL GROUP, INC. Finance/Rental/Leasing

Adam Sragovicz

Director of Finance/CFO

PRESIDIO PROPERTY TRUST, INC. Real Estate Investment Trusts

Adam Sragovicz

Director of Finance/CFO

Miscellaneous Commercial Services

David Tapolczay

Chief Executive Officer

Pharmaceuticals: Major

Glenn Mattes

Chairman

COGENT BIOSCIENCES, INC. Biotechnology

Zamaneh Mikhak

Chief Tech/Sci/R&D Officer

Stanford University College/University

Chele Farley

Graduate Degree

University of Pennsylvania College/University

Zamaneh Mikhak

Doctorate Degree

Boston University College/University

Zamaneh Mikhak

Undergraduate Degree

Miscellaneous Commercial Services

David Tapolczay

Chief Tech/Sci/R&D Officer

Glaxo Smithkline Plc /Clinical Pharmacology Unit/ Miscellaneous Commercial Services

David Tapolczay

Corporate Officer/Principal

University of Utah College/University

Dale J. Christensen

Doctorate Degree

Pharmaceuticals: Major

David Tapolczay

Chief Tech/Sci/R&D Officer

City University of New York College/University

Glenn Mattes

Undergraduate Degree

Yale University College/University

Adam Sragovicz

Undergraduate Degree

College/University

Adam Sragovicz

Graduate Degree

Miscellaneous Commercial Services

David Tapolczay

Corporate Officer/Principal

Miscellaneous Commercial Services

David Tapolczay

Chief Executive Officer

Miscellaneous Commercial Services

David Tapolczay

Chief Executive Officer

Miscellaneous Commercial Services

Chele Farley

Corporate Officer/Principal

Mistral Capital International LLC

Chele Farley

Corporate Officer/Principal

ARNO THERAPEUTICS, INC. Pharmaceuticals: Major

Glenn Mattes

Chief Executive Officer

Miscellaneous Commercial Services

David Tapolczay

Director/Board Member

Harvard Medical School College/University

Freda Lewis-Hall

Zamaneh Mikhak

Director/Board Member

Corporate Officer/Principal

Aryzun Pharmaceuticals

Dale J. Christensen

Corporate Officer/Principal

BICYCLE THERAPEUTICS PLC Biotechnology

David Tapolczay

Director/Board Member

GSK Group Ltd.

David Tapolczay

Corporate Officer/Principal

Biotechnology

David Tapolczay

Chairman

CANDEL THERAPEUTICS, INC. Biotechnology

Glenn Mattes

Director/Board Member

Pharmaceuticals: Major

David Tapolczay

Founder

Congregation Adat Yeshurun

Adam Sragovicz

Director/Board Member

Southampton Business School College/University

David Tapolczay

Doctorate Degree

Miscellaneous Commercial Services

Zamaneh Mikhak

Chief Tech/Sci/R&D Officer

KINIKSA PHARMACEUTICALS, LTD. Pharmaceuticals: Major

Zamaneh Mikhak

Director/Board Member

Stylacats Ltd.

David Tapolczay

Chief Executive Officer

NUFORMIX PLC Biotechnology

David Tapolczay

Founder

Miscellaneous Commercial Services

David Tapolczay

Director/Board Member

Miscellaneous Commercial Services

David Tapolczay

Director/Board Member

Nanoform Cardiovascular Therapeutics Ltd.

David Tapolczay

Director/Board Member

Investment Managers

Glenn Mattes

Consultant / Advisor

EAST IMPERIAL PLC Food Distributors

James Bligh

Director/Board Member

Tibotec Therapeutics, Inc.

Glenn Mattes

President

Mertz plc

James Bligh

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 27
Verenigd Koninkrijk 19
Israël 2
Roemenië 2

Sectoraal

Health Technology 13
Commercial Services 12
Consumer Services 11
Finance 4
Distribution Services 2

Operationeel

Director/Board Member 51
Corporate Officer/Principal 26
Independent Dir/Board Member 16
Chief Tech/Sci/R&D Officer 13
Undergraduate Degree 10
  1. Beurs
  2. Insiders
  3. Bill Begien
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU